Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

Cited by (1,041)

Items 101–200 of 1,041

1. Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma
   Zheng, Yi, Wang, Tingting, Tu, Xiaoxuan, Huang, Yun, Zhang, Hangyu, Tan, Di, Jiang, Weiqin, Cai, Shunfeng, Zhao, Peng, Song, Ruixue et al. · 2019 · Journal for ImmunoTherapy of Cancer
2. Anticancer effects of the microbiome and its products
   Zitvogel, Laurence, Daillère, Romain, Roberti, María Paula, Routy, Bertrand, Kroemer, Guido · 2017 · Nature Reviews Microbiology
3. Ginseng polysaccharides alter the gut microbiota and kynurenine/tryptophan ratio, potentiating the antitumour effect of antiprogrammed cell death 1/programmed cell death ligand 1 (anti-PD-1/PD-L1) immunotherapy
   Huang, Jumin, Liu, Di, Wang, Yuwei, Liu, Liang, Li, Jian, Yuan, Jing, Jiang, Zhihong, Jiang, Zebo, Hsiao, WL Wendy, Liu, Haizhou et al. · 2022 · Gut
4. The gut microbiota influences anticancer immunosurveillance and general health
   Routy, Bertrand, Gopalakrishnan, Vancheswaran, Daillère, Romain, Zitvogel, Laurence, Wargo, Jennifer A., Kroemer, Guido · 2018 · Nature Reviews Clinical Oncology
5. Aspects of Gut Microbiota and Immune System Interactions in Infectious Diseases, Immunopathology, and Cancer
   Veronica Lazăr, Lia-Mara Diţu, Grațiela Grădișteanu Pîrcălăbioru, Irina Gheorghe, Carmen Curuțiu, Alina Maria Holban, Ariana Aristina Picu, Laura Mădălina Petcu, Mariana Carmen Chifiriuc · 2018 · Frontiers in Immunology
6. Butyrate-producing human gut symbiont, Clostridium butyricum , and its role in health and disease
   Magdalena K. Stoeva, Jeewon Garcia-So, Nicholas Justice, Julia N. Myers, Surabhi Tyagi, Madeleine P. Nemchek, Paul J. McMurdie, Orville Kolterman, John S. Eid · 2021 · Gut Microbes
7. Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39
   Takenaka, Maisa C., Gabriely, Galina, Rothhammer, Veit, Mascanfroni, Ivan D., Wheeler, Michael A., Chao, Chun-Cheih, Gutiérrez-Vázquez, Cristina, Kenison, Jessica, Tjon, Emily C., Barroso, Andreia et al. · 2019 · Nature Neuroscience
8. Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons
   Adel Naimi, Rebar N. Mohammed, Ahmed Raji, Supat Chupradit, Alexei Valerievich Yumashev, Wanich Suksatan, Mohammed Nader Shalaby, Lakshmi Prasanth Thangavelu, Siavash Kamrava, Navid Shomali et al. · 2022 · Cell Communication and Signaling
9. Targeting the gut and tumor microbiota in cancer
   Park, Elizabeth M., Chelvanambi, Manoj, Bhutiani, Neal, Kroemer, Guido, Zitvogel, Laurence, Wargo, Jennifer A. · 2022 · Nature Medicine
10. Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer
    Coutzac, Clélia, Jouniaux, Jean-Mehdi, Paci, Angelo, Schmidt, Julien, Mallardo, Domenico, Seck, Atmane, Asvatourian, Vahe, Cassard, Lydie, Saulnier, Patrick, Lacroix, Ludovic et al. · 2020 · Nature Communications
11. Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies
    2022
12. Microbiome and Anticancer Immunosurveillance
    Zitvogel, Laurence, Ayyoub, Maha, Routy, Bertrand, Kroemer, Guido · 2016 · Cell
13. Personalized Mapping of Drug Metabolism by the Human Gut Microbiome
    Bahar Javdan, Jaime G Lopez, Pranatchareeya Chankhamjon, Ying-Chiang Jeffrey Lee, Raphaella Hull, Qihao Wu, Xiaojuan Wang, Seema Chatterjee, Mohamed S. Donia · 2020 · Cell
14. Airway microbiota is associated with upregulation of the PI3K pathway in lung cancer
    Tsay, Jun-Chieh J., Wu, Benjamin G., Badri, Michelle H., Clemente, Jose C., Shen, Nan, Meyn, Peter, Li, Yonghua, Yie, Ting-An, Lhakhang, Tenzin, Olsen, Evan et al. · 2018 · American Journal of Respiratory and Critical Care Medicine
15. Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1
    McCulloch, John A., Davar, Diwakar, Rodrigues, Richard R., Badger, Jonathan H., Fang, Jennifer R., Cole, Alicia M., Balaji, Ascharya K., Vetizou, Marie, Prescott, Stephanie M., Fernandes, Miriam R. et al. · 2022 · Nature Medicine
16. Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma
    Lee, Karla A., Thomas, Andrew Maltez, Bolte, Laura A., Björk, Johannes R., de Ruijter, Laura Kist, Armanini, Federica, Asnicar, Francesco, Blanco-Miguez, Aitor, Board, Ruth, Calbet-Llopart, Neus et al. · 2022 · Nature Medicine
17. Targeting T Cell Co-receptors for Cancer Therapy
    Margaret K. Callahan, Michael Andrew Postow, Jedd D. Wolchok · 2016 · Immunity
18. Human Gut Microbiota and Gastrointestinal Cancer
    Changting Meng, Chunmei Bai, Thomas David Brown, Leroy Hood, Qiang Tian · 2018 · Genomics Proteomics & Bioinformatics
19. The inflammatory microenvironment and microbiome in prostate cancer development
    Karen Sandell Sfanos, Srinivasan Yegnasubramanian, William G. Nelson, Angelo Michael De Marzo · 2017 · Nature Reviews Urology
20. Identification of bacteria-derived HLA-bound peptides in melanoma
    Kalaora, Shelly, Nagler, Adi, Nejman, Deborah, Alon, Michal, Barbolin, Chaya, Barnea, Eilon, Ketelaars, Steven L. C., Cheng, Kuoyuan, Vervier, Kevin, Shental, Noam et al. · 2021 · Nature
21. Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient
    Alejandro Jiménez-Sánchez, Danish Memon, Stephane Pourpe, Harini Veeraraghavan, Yanyun Li, Hebert Alberto Vargas, Michael B. Gill, Kay J. Park, Oliver Zivanovic, Jason A. Konner et al. · 2017 · Cell
22. Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Metastatic Melanoma
    Tuba Nur Gide, James S. Wilmott, Richard A. Scolyer, Georgina Venetia Long · 2017 · Clinical Cancer Research
23. The microbiome and gynaecological cancer development, prevention and therapy
    Paweł Łaniewski, Zehra Esra Ilhan, Melissa M. Herbst‐Kralovetz · 2020 · Nature Reviews Urology
24. Clinical utility of circulating non-coding RNAs — an update
    Simone Anfossi, Anna Babayan, Klaus Pantel, George A. Călin · 2018 · Nature Reviews Clinical Oncology
25. Untitled work
    2023 · 10.1038/s41392-022-01304-4
26. Role of tumor microenvironment in cancer progression and therapeutic strategy
    Qingjing Wang, Xueting Shao, Yuxuan Zhang, Miaojin Zhu, Frederick X.C. Wang, Jianjian Mu, Jiaxuan Li, Hangping Yao, Keda Chen · 2023 · Cancer Medicine
27. Resistance Mechanisms to Anti-PD Cancer Immunotherapy
    Vesely, Matthew D., Zhang, Tianxiang, Chen, Lieping · 2022 · Annual Review of Immunology
28. Is autoimmunity the Achilles' heel of cancer immunotherapy?
    June, Carl H, Warshauer, Jeremy T, Bluestone, Jeffrey A · 2017 · Nature Medicine
29. Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade
    Andrews, Miles C., Duong, Connie P. M., Gopalakrishnan, Vancheswaran, Iebba, Valerio, Chen, Wei-Shen, Derosa, Lisa, Khan, Md Abdul Wadud, Cogdill, Alexandria P., White, Michael G., Wong, Matthew C. et al. · 2021 · Nature Medicine
30. Metagenome-wide association studies: fine-mining the microbiome
    Wang, Jun, Jia, Huijue · 2016 · Nature Reviews Microbiology
31. The Cross-Talk Between Gut Microbiota and Lungs in Common Lung Diseases
    Dapeng Zhang, Sha Li, Ning Wang, Hor‐Yue Tan, Zhimin Zhang, Yibin Feng · 2020 · Frontiers in Microbiology
32. Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer
    Shanshan Jiang, Yile Xie, Xiuying Xiao, Zi‐Ran Kang, Xiaolin Lin, Lu Zhang, Chu-Shu Li, Yun Qian, Pingping Xu, Xiao-Xu Leng et al. · 2023 · Cell Host & Microbe
33. Role of Zinc in Immune System and Anti-Cancer Defense Mechanisms
    Dorota Skrajnowska, Barbara Bobrowska‐Korczak · 2019 · Nutrients
34. Strain Tracking Reveals the Determinants of Bacterial Engraftment in the Human Gut Following Fecal Microbiota Transplantation
    Christopher S. Smillie, Jenny S. Sauk, Dirk Gevers, Jonathan Friedman, Jaeyun Sung, Ilan Youngster, Elizabeth L. Hohmann, Christopher M. Staley, Alexander Khoruts, Michael Jay Sadowsky et al. · 2018 · Cell Host & Microbe
35. Immunotherapy in colorectal cancer: current achievements and future perspective
    Ahui Fan, Boda Wang, Xin Wang, Yongzhan Nie, Daiming Fan, Xiaodi Zhao, Yuanyuan Lu · 2021 · International Journal of Biological Sciences
36. Intratumoral accumulation of gut microbiota facilitates CD47-based immunotherapy via STING signaling
    Yaoyao Shi, Wenxin Zheng, Kaiting Yang, Katharine G. Harris, Kaiyuan Ni, Lai Xue, Wenbin Lin, Eugene B. Chang, Ralph R. Weichselbaum, Yang‐Xin Fu · 2020 · The Journal of Experimental Medicine
37. Diet, Microbiota and Gut-Lung Connection
    Swadha Anand, Sharmila S. Mande · 2018 · Frontiers in Microbiology
38. Innate immune signaling and regulation in cancer immunotherapy
    Corrales, Leticia, Matson, Vyara, Flood, Blake, Spranger, Stefani, Gajewski, Thomas F · 2017 · Cell Research
39. Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment
    Yanyun Gu, Xiaokai Wang, Junhua Li, Yifei Zhang, Huanzi Zhong, Ruixin Liu, Dongya Zhang, Qiang Feng, Xiaoyan Xie, Jie Hong et al. · 2017 · Nature Communications
40. Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophage
    Fluckiger, Aurélie, Daillère, Romain, Sassi, Mohamed, Sixt, Barbara Susanne, Liu, Peng, Loos, Friedemann, Richard, Corentin, Rabu, Catherine, Alou, Maryam Tidjani, Goubet, Anne-Gaëlle et al. · 2020 · Science
41. Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients
    Derosa, Lisa, Routy, Bertrand, Fidelle, Marine, Iebba, Valerio, Alla, Laurie, Pasolli, Edoardo, Segata, Nicola, Desnoyer, Aude, Pietrantonio, Filippo, Ferrere, Gladys et al. · 2020 · European Urology
42. Chronic stress promotes colitis by disturbing the gut microbiota and triggering immune system response
    Gao, Xinghua, Cao, Qiuhua, Cheng, Yan, Zhao, Dandan, Wang, Zhuo, Yang, Hongbao, Wu, Qijin, You, Linjun, Wang, Yue, Lin, Yanting et al. · 2018 · Proceedings of the National Academy of Sciences
43. Role of microbiota-derived short-chain fatty acids in cancer development and prevention
    Rasoul Mirzaei, Azam Afaghi, Sajad Babakhani, Masoudreza Sohrabi, Seyed Reza Hosseini‐Fard, Kiandokht Babolhavaeji, Shabnam Khani Ali Akbari, Rasoul Yousefimashouf, Sajad Karampoor · 2021 · Biomedicine & Pharmacotherapy
44. <i>Roseburia intestinalis</i> generated butyrate boosts anti-PD-1 efficacy in colorectal cancer by activating cytotoxic CD8 ⁺ T cells
    Kang, Xing, Liu, Changan, Ding, Yanqiang, Ni, Yunbi, Ji, Fenfen, Lau, Harry Cheuk Hay, Jiang, Lanping, Sung, Joseph JY, Wong, Sunny H, Yu, Jun · 2023 · Gut
45. Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms
    İbrahim Halil Şahin, Mehmet Akce, Olatunji Boladale Alese, Walid Labib Shaib, Gregory B. Lesinski, Bassel F. El‐Rayes, Christina Sing-Ying Wu · 2019 · British Journal of Cancer
46. Signal pathways of melanoma and targeted therapy
    Weinan Guo, Huina Wang, Chunying Li · 2021 · Signal Transduction and Targeted Therapy
47. γδ T cells: origin and fate, subsets, diseases and immunotherapy
    Yi Hu, Qinglin Hu, Yongsheng Li, Ligong Lu, Zheng Xiang, Zhinan Yin, Dieter Kabelitz, Yangzhe Wu · 2023 · Signal Transduction and Targeted Therapy
48. Lessons learned from the blockade of immune checkpoints in cancer immunotherapy
    Xiaolei Li, Changshun Shao, Yufang Shi, Weidong Han · 2018 · Journal of Hematology & Oncology
49. The role of gut microbiota in cancer treatment: friend or foe?
    Cheng, Wing Yin, Wu, Chun-Ying, Yu, Jun · 2020 · Gut
50. Modulating the microbiome to improve therapeutic response in cancer
    McQuade, Jennifer L, Daniel, Carrie R, Helmink, Beth A, Wargo, Jennifer A · 2019 · The Lancet Oncology
51. Thirty Years of Lactobacillus rhamnosus GG
    Lucio Capurso · 2019 · Journal of Clinical Gastroenterology
52. Cancer and the Microbiome—Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy
    Matson, Vyara, Chervin, Carolina Soto, Gajewski, Thomas F. · 2021 · Gastroenterology
53. Combining Immunotherapy and Radiotherapy for Cancer Treatment: Current Challenges and Future Directions
    Yifan Wang, Weiye Deng, Nan Li, Shinya Neri, Amrish Sharma, Wen Jiang, Steven Hsesheng Lin · 2018 · Frontiers in Pharmacology
54. Mechanisms regulating T-cell infiltration and activity in solid tumors
    Lanitis, E., Dangaj, D., Irving, M., Coukos, G. · 2017 · Annals of Oncology
55. Mechanisms of drug resistance in HCC
    Alexandra D. Ladd, Sérgio M. Duarte, İlyas Şahin, Ali Zarrinpar · 2023 · Hepatology
56. The Host Microbiome Regulates and Maintains Human Health: A Primer and Perspective for Non-Microbiologists
    Sunil Thomas, Jacques Izard, Emily K. Walsh, Kristen A. Batich, Pakawat Chongsathidkiet, Gerard A. Clarke, David A. Sela, Alexander J. Muller, James M. Mullin, Korin Albert et al. · 2017 · Cancer Research
57. <i>Enterococcus</i> peptidoglycan remodeling promotes checkpoint inhibitor cancer immunotherapy
    Griffin, Matthew E., Espinosa, Juliel, Becker, Jessica L., Luo, Ji-Dung, Carroll, Thomas S., Jha, Jyoti K., Fanger, Gary R., Hang, Howard C. · 2021 · Science
58. Gut microbiome in HCC – Mechanisms, diagnosis and therapy
    Robert F. Schwabe, Tim F. Greten · 2020 · Journal of Hepatology
59. Metabolic reprogramming for cancer cells and their microenvironment: Beyond the Warburg Effect
    Linchong Sun, Caixia Suo, Shiting Li, Huafeng Zhang, Ping Gao · 2018 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
60. Exploring immunotherapy in colorectal cancer
    Weng, Junyong, Li, Shanbao, Zhu, Zhonglin, Liu, Qi, Zhang, Ruoxin, Yang, Yufei, Li, Xinxiang · 2022 · Journal of Hematology &amp; Oncology
61. Gut microbiota and aging
    Zongxin Ling, Xia Liu, Yiwen Cheng, Xiumei Yan, Shaochang Wu · 2020 · Critical Reviews in Food Science and Nutrition
62. The Oral Microbiome and Cancer
    Irfan, Muhammad, Delgado, Renata Zoraida Rizental, Frias-Lopez, Jorge · 2020 · Frontiers in Immunology
63. Mechanisms of Cancer Resistance to Immunotherapy
    Rilan Bai, Naifei Chen, Lingyu Li, Nawen Du, Ling Bai, Zheng Lv, Huimin Tian, Jiuwei Cui · 2020 · Frontiers in Oncology
64. Moving towards personalized treatments of immune-related adverse events
    Esfahani, Khashayar, Elkrief, Arielle, Calabrese, Cassandra, Lapointe, Réjean, Hudson, Marie, Routy, Bertrand, Miller, Wilson H., Calabrese, Leonard · 2020 · Nature Reviews Clinical Oncology
65. Microbiome and colorectal cancer: Roles in carcinogenesis and clinical potential
    Ester Saus, Susana Iraola‐Guzmán, Jesse R. Willis, Anna Brunet‐Vega, Toni Gabaldón · 2019 · Molecular Aspects of Medicine
66. Bacteria in cancer initiation, promotion and progression
    Geniver El Tekle, Wendy S. Garrett · 2023 · Nature reviews. Cancer
67. Probiotic Bacteria: A Promising Tool in Cancer Prevention and Therapy
    Górska, Agata, Przystupski, Dawid, Niemczura, Magdalena J., Kulbacka, Julita · 2019 · Current Microbiology
68. Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
    Smith, Melody, Dai, Anqi, Ghilardi, Guido, Amelsberg, Kimberly V., Devlin, Sean M., Pajarillo, Raymone, Slingerland, John B., Beghi, Silvia, Herrera, Pamela S., Giardina, Paul et al. · 2022 · Nature Medicine
69. Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation
    Peled, Jonathan U., Devlin, Sean M., Staffas, Anna, Lumish, Melissa, Khanin, Raya, Littmann, Eric R., Ling, Lilan, Kosuri, Satyajit, Maloy, Molly, Slingerland, John B. et al. · 2017 · Journal of Clinical Oncology
70. The Role of the Gut Microbiome in Colorectal Cancer Development and Therapy Response
    Lidia Sánchez‐Alcoholado, Bruno Ramos‐Molina, Ana Pardessus Otero, Aurora Laborda-Illanes, Rafael Ordóñez, José Antonio Medina, Jaime Gómez‐Millán, María Isabel Queipo‐Ortuño · 2020 · Cancers
71. Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis
    Pernigoni, Nicolò, Zagato, Elena, Calcinotto, Arianna, Troiani, Martina, Mestre, Ricardo Pereira, Calì, Bianca, Attanasio, Giuseppe, Troisi, Jacopo, Minini, Mirko, Mosole, Simone et al. · 2021 · Science
72. Bifidobacterium bifidum strains synergize with immune checkpoint inhibitors to reduce tumour burden in mice
    Lee, Se-Hoon, Cho, Sung-Yup, Yoon, Youngmin, Park, Changho, Sohn, Jinyoung, Jeong, Jin-Ju, Jeon, Bu-Nam, Jang, Mongjoo, An, Choa, Lee, Suro et al. · 2021 · Nature Microbiology
73. A Microbiota-Derived Bacteriocin Targets the Host to Confer Diarrhea Resistance in Early-Weaned Piglets
    Jun Hu, Libao Ma, Yangfan Nie, Jianwei Chen, Wenyong Zheng, Xinkai Wang, Chunlin Xie, Zilong Zheng, Zhichang Wang, Tao Yang et al. · 2018 · Cell Host & Microbe
74. Bioaccumulation of therapeutic drugs by human gut bacteria
    Martina Klünemann, Sergej Andrejev, Sonja Blasche, André Mateus, Prasad B. Phapale, Saravanan Devendran, Johanna Vappiani, Bernd Simon, Timothy A. Scott, Eleni Kafkia et al. · 2021 · Nature
75. Factors involved in cancer metastasis: a better understanding to “seed and soil” hypothesis
    Qiang Liu, Hongfei Zhang, Xiaoli Jiang, Caiyun Qian, Zhuoqi Liu, Daya Luo · 2017 · Molecular Cancer
76. Vulnerability of the industrialized microbiota
    Justin Laine Sonnenburg, Erica Dutil Sonnenburg · 2019 · Science
77. The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer
    Mirji, Gauri, Worth, Alison, Bhat, Sajad Ahmad, El Sayed, Mohamed, Kannan, Toshitha, Goldman, Aaron R., Tang, Hsin-Yao, Liu, Qin, Auslander, Noam, Dang, Chi V. et al. · 2022 · Science Immunology
78. Memory T cells: strategies for optimizing tumor immunotherapy
    Qingjun Liu, Zhongjie Sun, Ligong Chen · 2020 · Protein & Cell
79. Fecal microbiota transplantation in cancer management: Current status and perspectives
    Danfeng Chen, Jingyi Wu, Duochen Jin, Bangmao Wang, Hailong Cao · 2018 · International Journal of Cancer
80. The mutual interplay of gut microbiota, diet and human disease
    Placido Illiano, Roberta Brambilla, Cinzia Parolini · 2020 · FEBS Journal
81. Gut microbiome, big data and machine learning to promote precision medicine for cancer
    Cammarota, Giovanni, Ianiro, Gianluca, Ahern, Anna, Carbone, Carmine, Temko, Andriy, Claesson, Marcus J., Gasbarrini, Antonio, Tortora, Giampaolo · 2020 · Nature Reviews Gastroenterology &amp; Hepatology
82. Lower Airway Dysbiosis Affects Lung Cancer Progression
    Tsay, Jun-Chieh J., Wu, Benjamin G., Sulaiman, Imran, Gershner, Katherine, Schluger, Rosemary, Li, Yonghua, Yie, Ting-An, Meyn, Peter, Olsen, Evan, Perez, Luisannay et al. · 2021 · Cancer Discovery
83. The Gut Microbiome Associates with Immune Checkpoint Inhibition Outcomes in Patients with Advanced Non–Small Cell Lung Cancer
    Hakozaki, Taiki, Richard, Corentin, Elkrief, Arielle, Hosomi, Yukio, Benlaïfaoui, Myriam, Mimpen, Iris, Terrisse, Safae, Derosa, Lisa, Zitvogel, Laurence, Routy, Bertrand et al. · 2020 · Cancer Immunology Research
84. Microbiota-specific T follicular helper cells drive tertiary lymphoid structures and anti-tumor immunity against colorectal cancer
    Overacre-Delgoffe, Abigail E., Bumgarner, Hannah J., Cillo, Anthony R., Burr, Ansen H.P., Tometich, Justin T., Bhattacharjee, Amrita, Bruno, Tullia C., Vignali, Dario A.A., Hand, Timothy W. · 2021 · Immunity
85. Biomarkers of response to PD-1/PD-L1 inhibition
    Saman Maleki Vareki, Carmen Garrigós, Ignacio Durán · 2017 · Critical Reviews in Oncology/Hematology
86. Exploring the emerging role of the microbiome in cancer immunotherapy
    Jessica L. Fessler, Vyara Z. Matson, Thomas Frank Gajewski · 2019 · Journal for ImmunoTherapy of Cancer
87. Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer
    S. Zhang, Yongzhi Peter Yang, Wenhao Weng, Bomin Guo, Guoxiang Cai, Yanlei Ma, Sanjun Cai · 2019 · Journal of Experimental & Clinical Cancer Research
88. Tumor microenvironment signaling and therapeutics in cancer progression
    Goenka, Anshika, Khan, Fatima, Verma, Bhupender, Sinha, Priyanka, Dmello, Crismita C., Jogalekar, Manasi P., Gangadaran, Prakash, Ahn, Byeong‐Cheol · 2023 · Cancer Communications
89. Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy
    Daixi Ren, Yuze Hua, Boyao Yu, Xin Ye, Ziheng He, Chunwei Li, Jie Wang, Yongzhen Mo, Xiaoxu Wei, Yunhua Chen et al. · 2020 · Molecular Cancer
90. Microbiota, Inflammation and Colorectal Cancer
    Cécily Lucas, Nicolas Barnich, Hang Thi Thu Nguyen · 2017 · International Journal of Molecular Sciences
91. Current Challenges in Cancer Immunotherapy: Multimodal Approaches to Improve Efficacy and Patient Response Rates
    Manpreet Sambi, Leila Bagheri, Myron R. Szewczuk · 2019 · Journal of Oncology
92. Unexpected guests in the tumor microenvironment: microbiome in cancer
    Abigail Wong-Rolle, Haohan Karen Wei, Chen Ning Zhao, Chengcheng Jin · 2020 · Protein & Cell
93. 16S rRNA amplicon sequencing identifies microbiota associated with oral cancer, human papilloma virus infection and surgical treatment
    Rafael E. Guerrero-Preston, Filipa Godoy‐Vitorino, Anne Jedlicka, Arnold Rodríguez-Hilario, Herminio González, Jessica Bondy, Fahcina P. Lawson, Oluwasina Folawiyo, Christina Michailidi, Amanda Dziedzic et al. · 2016 · Oncotarget
94. Tissue-specific tumorigenesis: context matters
    Günter Schneider, Marc Schmidt‐Supprian, Roland Rad, Dieter Saur · 2017 · Nature reviews. Cancer
95. Gut microbiota injury in allogeneic haematopoietic stem cell transplantation
    Yusuke Shono, Marcel R.M. van den Brink · 2018 · Nature reviews. Cancer
96. Microbiota in pancreatic health and disease: the next frontier in microbiome research
    Ryan Michael Thomas, Christian Jobin · 2019 · Nature Reviews Gastroenterology & Hepatology
97. Microbiota-gut-brain axis and the central nervous system
    Zhu, Xiqun, Han, Yong, Du, Jing, Liu, Renzhong, Jin, Ketao, Yi, Wei · 2017 · Oncotarget
98. Microbiota Depletion Impairs Thermogenesis of Brown Adipose Tissue and Browning of White Adipose Tissue
    Li, Baoguo, Li, Li, Li, Min, Lam, Sin Man, Wang, Guanlin, Wu, Yingga, Zhang, Hanlin, Niu, Chaoqun, Zhang, Xueying, Liu, Xue et al. · 2019 · Cell Reports
99. Gut Microbiota in Cancer Immune Response and Immunotherapy
    Cheng‐Bei Zhou, Yilu Zhou, Jing‐Yuan Fang · 2021 · Trends in cancer
100. Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies
     Concetta Panebianco, Angelo Andriulli, Valerio Pazienza · 2018 · Microbiome